---
$id: https://graph.org.ai/products/commodity/51271625
$type: Product
source: UNSPSC
code: "51271625"
title: "Butanilicaine phosphate"
class: "51271600"
classTitle: "Anaesthetic amides"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Butanilicaine phosphate

**UNSPSC Code**: 51271625
**Class**: [Anaesthetic amides](Anaesthetic amides.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent with the molecular formula C13H19CLN2O.H3O4P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JOZ20TRV0N. European Medicines Agency schedules butanilicaine phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00912MIG. The term butanilicaine phosphate is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule butanilicaine phosphate under HS 29242995 and SITC 51479. As of Q4 2014, BUTANILICAINE PHOSPHATE remains US FDA's Preferred Term for this commodity. Butanilicaine phosphate bears US NLM identifiers UMLS ID C0888854 and NCI Concept Code C97305. SMILES: CCCCNCC(=O)NC1C(CCCC1CL)C.OP(=O)(O)O.

